Press "Enter" to skip to content

New patent expiration for Mitsubishi Tanabe drug RADICAVA

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Mitsubishi Tanabe drug RADICAVA

Annual Drug Patent Expirations for RADICAVA
Annual Drug Patent Expirations for RADICAVA

Radicava is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has seven patent family members in six countries.

The generic ingredient in RADICAVA is edaravone. One supplier is listed for this compound. Additional details are available on the edaravone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Mitsubishi Tanabe drug RADICAVA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!